Capillary Blood Collection Devices Market Size & Share 2024 - 2032

Capillary Blood Collection Devices Market Size

Capillary Blood Collection Devices Market size was valued at around USD 1.8 Billion in 2023 and is estimated to grow at 7.7% CAGR from 2024 to 2032. Capillary blood collection devices are medical tools designed for the collection of small blood samples from capillaries, typically from the fingertip. These devices are commonly used in healthcare settings, blood centers, etc. for diagnostic, monitoring, and screening purposes.

According to the World Health Organization, global blood donations amount to approximately 118 million, with 40% of these donations originating from high-income countries, which constitute only 16% of the world's population. There are around 13,300 blood centers across 169 countries contribute to the blood collection.
 

Furthermore, the increasing prevalence of chronic diseases, such as diabetes, is contributing to the demand for capillary blood collection devices. Regular blood glucose monitoring, often facilitated by these diabetes care devices that exhibit a growth rate of 9.5% CAGR, is essential for managing and controlling chronic conditions.
 

Capillary Blood Collection Devices Market Trends

The growing emphasis on point of care testing (POCT) represents a significant trend in the healthcare industry, with notable implications for the demand and utilization of capillary blood collection devices. Point-of-care testing involves conducting diagnostic tests at or near the location where patient care is provided, rather than sending samples to a centralized laboratory. This shift towards decentralized testing has been facilitated by advancements in technology and has several key implications.
 

• Point-of-care testing allows for the generation of rapid and immediate test results. Capillary blood collection devices play a crucial role in this process by providing a quick and convenient method for obtaining blood samples at the point of care. This immediacy is particularly valuable in emergency situations and for time-sensitive medical decisions.
   
• Point-of-care testing, often utilizing capillary blood samples, brings diagnostics closer to patients, improving accessibility to healthcare services. This is particularly beneficial in remote or resource-limited settings where access to centralized laboratories may be challenging.
   

Capillary Blood Collection Devices Market Analysis

Based on product type, the market is segmented into micro-container tubes, micro-hematocrit tubes, warming devices, lancing devices, and other product types. The lancing devices segment is poised for significant growth at a CAGR of 8% during the forecast period. The segment is further bifurcated into adjustable lancing devices and non-adjustable lancing devices.
 

• Continuous advancements in lancing device technology are focusing on enhancing user experience, reducing pain, and improving the efficiency of blood collection. Some innovations include adjustable depth settings, precision-guided lancing, and integrated features for ease of use.
   
• The integration of lancing devices with glucose monitoring systems is a notable trend. This allows for a seamless and integrated blood glucose monitoring experience, often with features like Bluetooth connectivity for real-time data tracking and analysis.
   
• The development of needle-free lancing technologies is gaining attention. These technologies aim to reduce the pain associated with traditional needle-based lancing devices, making blood collection more comfortable for users, especially those requiring frequent monitoring, such as individuals with diabetes.

Learn more about the key segments shaping this market

Download Free PDF

Based on material, the capillary blood collection devices market is segmented into plastic, glass, and other materials. The plastic segment accounted for a revenue share of 59.4% in 2023 and is estimated to follow similar trend over the coming years.
 

• Ongoing advancements in plastic materials, such as new formulations of polypropylene, are likely to impact the design and performance of capillary blood collection devices. These materials offer benefits such as improved durability, flexibility, and compatibility with various sterilization methods.
   
• There may be a trend toward the use of bio-compatible materials in capillary blood collection devices. Materials that minimize the risk of adverse reactions and enhance patient safety could become more prominent in the design of these devices.
   
• Furthermore, transparency of materials, particularly in capillary tubes, remains crucial for visual inspection during blood collection procedures. Materials with enhanced transparency and clarity might be favored to ensure accurate observation and reliable results.
   

The capillary blood collection devices market by application is categorized into glucose monitoring, hematocrit testing, cholesterol testing, coagulation testing, and other applications. The glucose monitoring segment accounted for around USD 499.9 million revenue size in 2023.
 

• Capillary blood collection devices are extensively used for glucose monitoring, especially in the context of diabetes management. These devices include lancing devices for blood sample collection, capillary tubes for transferring the blood to test strips, and glucose meters for analyzing blood glucose levels.
   
• The emphasis on regular and convenient glucose monitoring has driven innovation in capillary blood collection devices to make the process more user-friendly for individuals managing diabetes.
   
• Capillary blood collection is widely employed in hematology for tests such as hematocrit determination, hemoglobin analysis, and complete blood count (CBC). Microtainer tubes and capillary tubes are commonly used in this application for collecting small volumes of blood for diagnostic purposes.
   

The capillary blood collection devices market by end-use is categorized into hospitals and clinics, blood banks, diagnostic centers, home diagnosis, and other end-users. The hospitals and clinics segment accounted for around USD 571 million revenue size in 2023.
 

• Hospitals and clinics are increasingly adopting point-of-care testing using capillary blood collection devices. This trend is driven by the need for rapid and immediate diagnostic results at the patient's bedside, allowing for quicker decision-making and timely interventions.
   
• The trend towards home healthcare is influencing the market. Devices that are user-friendly and suitable for at-home use, especially for conditions like diabetes, are gaining popularity.
   
• Hospitals and clinics are placing a stronger emphasis on patient-centric care. Capillary blood collection devices that prioritize patient comfort, reduce pain, and offer ease of use are becoming preferred choices, contributing to better patient experiences.

North America capillary blood collection devices market accounted for USD 798.7 million revenue in 2023 and is predicted to witness substantial market expansion.
 

• There is a noticeable trend toward home healthcare in North America, driven by factors such as an aging population, the prevalence of chronic diseases, and the desire for patient-centric care. Capillary blood collection devices that cater to at-home use, especially for conditions like diabetes, are gaining prominence.
   
• The increasing prevalence of diabetes in North America is a significant driver for the market. As diabetes management often involves regular blood glucose monitoring, the demand for user-friendly and efficient blood collection tools has grown.
   
• Ongoing technological advancements in capillary blood collection devices, including improved lancing devices and microsampling techniques, are influencing the market. The region is witnessing the integration of innovative technologies to enhance the accuracy and efficiency of blood collection processes.
   

Capillary Blood Collection Devices Market Share

The capillary blood collection devices industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, among others have a notable presence in the market.
 

Capillary Blood Collection Devices Market Companies

Some of the eminent market participants operating in the capillary blood collection devices industry include:

• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health
• Greiner Bio-One International GmbH
• Medtronic plc
• Radiometer Medical ApS
• Roche Diagnostics
• Sarstedt AG & Co.
• Siemens Healthineers
• Terumo Corporation
   

Capillary Blood Collection Devices Industry News:

• In December 2023, Becton, Dickinson and Company announced that it had received FDA 510(k) clearances for a novel blood collection device, the BD MiniDraw Collection System. This device allowed low-volume blood collection for lipid panels, selected chemistry tests, and hemoglobin/hematocrit (H&H) testing through fingersticks, producing lab-quality results. The approval of the product contributed to the company's expansion of its portfolio of blood tests.
   
• In February 2020, Becton, Dickinson and Company and Babson Diagnostics had announced a long-term strategic partnership agreement. The collaboration aimed to bring laboratory-quality, small-volume blood collection services to retail pharmacies. This partnership aligned with past healthcare trends, emphasizing quicker, more affordable laboratory testing in customer-friendly healthcare settings with convenient hours and locations. Such partnership helped in rapid growth in the diagnostic testing market.
   

Capillary blood collection devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Micro-container tubes        
• Micro-hematocrit tubes      
• Warming devices     
• Lancing devices       
  • Adjustable lancing devices
  • Non-adjustable lancing devices     
• Other product types

Market, By Material

• Plastic
• Glass
• Other materials

Market, By Application

• Glucose monitoring
• Hematocrit testing
• Cholesterol testing
• Coagulation testing
• Other applications

Market, By End-use

• Hospitals and clinics
• Blood banks
• Diagnostic centers
• Home diagnosis
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa